BIIB vs NVRI · P/E 21, rev $9.89B vs rev $511.4M
Biogen Inc (BIIB) versus Enviri Corporation (NVRI) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Enviri Corporation (NVRI) is a waste management company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported NVRI revenue for 2026-06-30 was $511.4M. Net income was -$406.7M. Revenue was down 7.0% from 2026-03-31 to 2026-06-30. NVRI currently screens at market cap $553.8M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. NVRI currently screens at market cap $553.8M.
Not investment advice. Open the BIIB and NVRI stock pages for the full models.
Not investment advice.